{
  "id": 2803428,
  "title": "Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps",
  "url": "https://urgent.news/2026/08/23/real-world-study-backs-mepolizumab-in-rhinosinusitis-with-nasal-polyps",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-23T14:00:00.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/pulmonology/generalpulmonary/122714"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Mepolizumab (Nucala) improved outcomes for adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and put about one in five on the way to remission, a real-life study from Italy showed. The nasal polyp score dropped...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}